Bill and Melinda Gates Foundation announced investing in the amount of $ 120 million to the Merck laboratory, which developed tablets from coronavirus.
It is noted that it will help poor countries that have difficulty vaccination. The first 10 million tablets are planned to produce by the end of 2021, but there is a risk that poor countries may not get long-awaited preparations from COVID-19.
“Global vaccine supplies were bought by rich countries. We must prevent the repetition of this,” said Novartis Pharma AG Trevor Mandel in an interview with AFP interviews.
Some pharmaceutical companies also stated that they can produce about 10 million drugs per month, but doubt the demand for pills from coronavirus.